AIHW Board AIHW senior staff Annual report Capability statement Collaboration AIHW corporate plan 2016–17 to 2019–20 Customer care charter FOI - freedom of information Indexed list of files Nous review Organisation chart Presentations Privacy of data Public Interest Disclosure Tenders
By category Ageing, disability & carers Families & children Hospitals Housing & homelessness Indigenous Australians Population groups Risk factors, diseases & death Services, workforce & spending
By subject Adoptions Aged care Ageing Alcohol & other drugs Arthritis & musculoskeletal conditions Asthma Australia's health Australia's welfare Burden of disease Cancer Cardiovascular disease Child health, development & wellbeing Child protection Children's services Chronic diseases
Chronic kidney disease Chronic respiratory conditions COPD Deaths Dementia Dental & oral health Diabetes Disability Expenditure Eye health Food & nutrition Health indicators Health performance Homelessness Hospitals Housing assistance Indigenous Australians Injury Life expectancy
Male health Mental health Mothers & babies Overweight & obesity Palliative care services Population health Primary health care Prisoner health Risk factors Rural health Safety & quality of health care Veterans' health Workforce Youth health & wellbeing Youth justice
In other sections Data Publications Contact AIHW
Publications CatalogueOrdering publicationsForthcoming publications Online reports Subscribe to release notices
By subject Adoptions Aged care Ageing Alcohol & other drugs AIHW annual reports Arthritis & musculoskeletal conditions Asthma Australia's health Australia's welfare Burden of disease Cancer Cardiovascular disease Child health, development & wellbeing Child protection Children's services Chronic diseases Chronic kidney disease
Chronic respiratory conditions Corporate publications Data linkage Data standards Deaths Dental & oral health Diabetes Disability Expenditure Eye health Food & nutrition General practice Health indicators Health performance Homelessness Hospitals Housing assistance Indigenous Australians Indigenous housing
Injury Life expectancy Male health Mental health services Mothers & babies Overweight & obesity Palliative care Population health Primary health carePrisoner health Risk factors Rural health Safety & quality of health care Veterans' health Workforce Youth health & wellbeing Youth justice
In other sections Subjects Data Contact AIHW
About AIHW data METeOR—metadata online registry Data by subject AIHW data collections Customised data analysis request Data governance framework Data linking Data standards GovHack Privacy of data Accessing Australian Government health and welfare data
By subjectAboriginal and Torres Strait Islander Health Performance Framework Adoptions Aged care Alcohol and other drugs Alcohol data sources Cancer Children's headline indicators (CHI) Child protection Data sources for monitoring health conditionsDeaths Diabetes Disability
Expenditure FHBH - Fixing houses for better health General Record of Incidence of Mortality (GRIM) books Hospitals Indigenous Australians International collaboration Maternity Information Matrix (MIM) Medical indemnity Mental health Mortality Over Regions and Time (MORT) books National Aged Care Data Clearinghouse
National core maternity indicators (NCMI) National framework for protecting Australia’s children (NFPAC) National indicator catalogue National Youth Information Framework (NYIF) Perinatal data Primary Health Network (PHN) Priority Investment Approach dataset Specialist Homelessness Services (SHS) Workforce
In other sections Subjects Publications Contact AIHW
AIHW committeesAIHW Board AIHW Ethics Committee
National & advisory committeesACFADD AHSAC AODTS NMDS WG Cancer CKDMAC CVDMAC HEACIGIHM JJ RIG MHISSC
NAGATSIHID NCSIMG NDDWG NDIMG NHISSC NIAG NIRAPIMG NMDDNMDS NMHPSC NOPSAD
NPDDC NPHEP NPHIC PCDWG PDWG PHIDG PHIG REDWG Workforce committees
In other sections About the AIHW Data Publications Contact AIHW
Education worksheets Infographics What's in the pipeline Subscribe to education notices Other educational links
Resources by subject All Latest Ageing Australia's health Australia's welfare Carers
Children & youth Disability Disease Drugs
Health Health prevention Indigenous Australians Injury
In other sections Subjects Data Publications Contact AIHW
Job vacancies How to apply for a position at the AIHW Conditions of employment Benefits of working for the AIHW Temporary employment register Occupational Training Program Contact the People Unit Graduates
AIHW Access magazine Media releases Subscribe to release notices Embargoed access to AIHW material Media contacts
You are here:
Kidney cancer incorporates ICD-10 cancer code C64 (Malignant neoplasm of kidney).
Kidney cancer was the 9th most commonly diagnosed cancer in Australia in 2013. It is estimated that it will remain the 9th most commonly diagnosed cancer in 2017.
In 2013, there were 3,059 new cases of kidney cancer diagnosed in Australia (1,987 males and 1,071 females). In 2017, it is estimated that 3,512 new cases of kidney cancer will be diagnosed in Australia (2,256 males and 1,256 females).
In 2013, the age-standardised incidence rate was 12 cases per 100,000 persons (16 for males and 8.1 for females). In 2017, it is estimated that the age-standardised incidence rate will be 12 cases per 100,000 persons (17 for males and 8.5 for females). The incidence rate of kidney cancer is expected to generally increase with age up to age group 75–79; then slightly decrease for older age groups (Figure 1).
In 2017, it is estimated that the risk of an individual being diagnosed with kidney cancer by their 85th birthday will be 1 in 65 (1 in 49 males and 1 in 95 females).
The number of new cases of kidney cancer diagnosed increased from 793 (534 males and 259 females) in 1982 to 3,059 in 2013. Over the same period, the age-standardised incidence rate increased from 6.2 cases per 100,000 persons (9.4 for males and 3.7 for females) in 1982 to 12 cases per 100,000 persons in 2013 (Figure 2).
In 2014, kidney cancer was the 18th most common cause of cancer death in Australia. It is estimated that it will become the 17th most common cause of death from cancer in 2017.
In 2014, there were 920 deaths from kidney cancer in Australia (574 males and 346 females). In 2017, it is estimated that this will increase to 1,049 deaths (681 males and 368 females).
In 2014, the age-standardised mortality rate was 3.4 deaths per 100,000 persons (4.6 for males and 2.3 for females). In 2017, it is estimated that the age-standardised mortality rate will be 3.5 deaths per 100,000 persons (5.0 for males and 2.2 for females). The mortality rate for kidney cancer is generally expected to increase with age (Figure 1).
In 2017, it is estimated that the risk of an individual dying from kidney cancer by their 85th birthday will be 1 in 216 (1 in 152 males and 1 in 347 females).
The number of deaths from kidney cancer increased from 300 (190 males and 110 females) in 1968 to 920 in 2014. Over the same period, the age-standardised mortality rate remained fairly consistent, with 3.3 deaths per 100,000 persons (4.6 for males and 2.3 for females) in 1968 to 3.4 deaths per 100,000 persons in 2014 (Figure 2).
Source: AIHW .
Source: AIHW .
In 2009–2013 in Australia, individuals diagnosed with kidney cancer had a 75% chance (75% for males and 76% for females) of surviving for 5 years compared to their counterparts in the general Australian population.
Between 1984–1988 and 2009–2013, 5-year relative survival from kidney cancer improved from 49% to 75%.
The survivorship population is measured using prevalence data. Prevalence refers to the number of people alive who have previously been diagnosed with kidney cancer.
The prevalence for 1, 5 and 31 years given below are the number of people living with kidney cancer at the end of 2012 who had been diagnosed in the preceding 1, 5 and 31 years respectively.
At the end of 2012, there were 2,825 people living who had been diagnosed with kidney cancer that year, 11,058 people who had been diagnosed with kidney cancer in the previous 5 years (from 2008 to 2012) and 25,852 people who had been diagnosed with kidney cancer in the previous 31 years (from 1982 to 2012).
More information on kidney cancer from Cancer Australia
Cancer is classified by the International Statistical Classification of Diseases and Related Health Problems Version 10 (ICD-10). This is a statistical classification, published by the World Health Organization, in which each morbid condition is assigned a unique code according to established criteria.
Future estimations for incidence and mortality are a mathematical extrapolation of past trends. They assume that the most recent trends will continue into the future, and are intended to illustrate future changes that might reasonably be expected to occur if the stated assumptions continue to apply over the estimated period. Actual future cancer incidence and mortality rates may vary from these estimations. For instance, new screening programs may increase the detection of new cancer cases; new vaccination programs may decrease the risk of developing cancer; and improvements in treatment options may decrease mortality rates.
Cancer incidence indicates the number of new cancers diagnosed during a specified time period (usually one year).
The 2013 national incidence counts include estimates for NSW because the actual data were not available. Note that actual data for the Australian Capital Territory do not include cases identified from death certificates.
The 2017 estimates are based on 2004–13 incidence data. Due to rounding of these estimates, male and female incidence may not sum to person incidence.
Cancer mortality refers to the number of deaths occurring during a specified time period (usually one year) for which the underlying cause of death is cancer.
The 2017 estimates are based on mortality data up to 2013. Joinpoint analysis was used on the longest time series of age-standardised rates available to determine the starting year of the most recent trend.
Prevalence of cancer refers to the number of people alive with a prior diagnosis of cancer at a given time. It is distinct from incidence, which is the number of new cancers diagnosed within a given period of time. The longest period for which it is possible to calculate prevalence using the available national data (from 1982 to 2012) is currently 31 years so this is used to provide an estimate of the ‘total’ prevalence of cancer as at the end of 2012, noting that people diagnosed with cancer before 1982 aren’t included.
Incidence and mortality rates expressed per 100,000 population are age-standardised to the Australian population as at 30 June 2001.